Thompson Jaye's Form 4 filing
Greenwich LifeSciences, Inc. (GLSI) · filed Jul 17, 2023
- Accession no.
- 0001493152-23-024661
- Filed
- Jul 17, 2023
- Trade date
- Jul 13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.37K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson JayeCIK 0001476971 | Officer (VP Clinical Reg Affairs) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | Common Stock | PPurchaseAcquired | +250 | $9.49 | +$2,372.5 | 259,248 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.